-
13941por Lifson, Alan R, Krantz, Elizabeth M, Grambsch, Patricia L, Macalino, Grace E, Crum-Cianflone, Nancy F, Ganesan, Anuradha, Okulicz, Jason F, Eaton, Anne, Powers, John H, Eberly, Lynn E, Agan, Brian K“…CD4+ ≥ 500, HR = 2.97), greater HIV RNA level (HR = 1.36 per one log(10 )increase), hepatitis C antibody or chronic hepatitis B (HR = 1.96), and HIV diagnosis before 1996 (HR = 2.44). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13942por Keck, Zhen-yong, Xia, Jinming, Wang, Yong, Wang, Wenyan, Krey, Thomas, Prentoe, Jannick, Carlsen, Thomas, Li, Angela Ying-Jian, Patel, Arvind H., Lemon, Stanley M., Bukh, Jens, Rey, Felix A., Foung, Steven K. H.“…The majority of broadly neutralizing antibodies to hepatitis C virus (HCV) are against conformational epitopes on the E2 glycoprotein. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13943“…BACKGROUND: Hepatitis C virus displays a high rate of mutation and exists as a quasispecies in infected patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13944por Vermehren, Johannes, Vermehren, Annika, Mueller, Axel, Carlebach, Amina, Lutz, Thomas, Gute, Peter, Knecht, Gaby, Sarrazin, Christoph, Friedrich-Rust, Mireen, Forestier, Nicole, Poynard, Thierry, Zeuzem, Stefan, Herrmann, Eva, Hofmann, Wolf Peter“…METHODS: In 202 consecutive HIV-infected individuals (159 men; mean age 47 ± 9 years; 35 with hepatitis-C-virus [HCV] co-infection), TE and FT were performed. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13945por Lee, Hsin-Ya, Li, Jih-Heng, Wu, Li-Tzy, Wu, Jin-Song, Yen, Cheng-Fang, Tang, Hsin-Pei“…Past amphetamine use, co-infection with hepatitis C, and a longer retention in the MMTP were associated with increased odds of co-medication. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13946por Garvey, Lucy J., Pavese, Nicola, Ramlackhansingh, Anil, Thomson, Emma, Allsop, Joanna M., Politis, Marios, Kulasegaram, Ranjababu, Main, Janice, Brooks, David J., Taylor-Robinson, Simon D., Winston, Alan“…BACKGROUND: Microglial cell activation and cerebral function impairment are described in both chronic hepatitis C viral (HCV) and Human-Immune-Deficiency viral (HIV) infections. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13947por Morin, Trevor J., Broering, Teresa J., Leav, Brett A., Blair, Barbra M., Rowley, Kirk J., Boucher, Elisabeth N., Wang, Yang, Cheslock, Peter S., Knauber, Michael, Olsen, David B., Ludmerer, Steve W., Szabo, Gyongyi, Finberg, Robert W., Purcell, Robert H., Lanford, Robert E., Ambrosino, Donna M., Molrine, Deborah C., Babcock, Gregory J.“…Hepatitis C virus (HCV) infection is a leading cause of liver transplantation and there is an urgent need to develop therapies to reduce rates of HCV infection of transplanted livers. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13948por Kwong, Jeffrey C., Ratnasingham, Sujitha, Campitelli, Michael A., Daneman, Nick, Deeks, Shelley L., Manuel, Douglas G., Allen, Vanessa G., Bayoumi, Ahmed M., Fazil, Aamir, Fisman, David N., Gershon, Andrea S., Gournis, Effie, Heathcote, E. Jenny, Jamieson, Frances B., Jha, Prabhat, Khan, Kamran M., Majowicz, Shannon E., Mazzulli, Tony, McGeer, Allison J., Muller, Matthew P., Raut, Abhishek, Rea, Elizabeth, Remis, Robert S., Shahin, Rita, Wright, Alissa J., Zagorski, Brandon, Crowcroft, Natasha S.“…The most burdensome infectious agents were: hepatitis C virus, Streptococcus pneumoniae, Escherichia coli, human papillomavirus, hepatitis B virus, human immunodeficiency virus, Staphylococcus aureus, influenza virus, Clostridium difficile, and rhinovirus. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13949por Badiger, Rekha, Mitchell, Jane A., Gashaw, Hime, Galloway-Phillipps, Neil A., Foser, Stefan, Tatsch, Fernando, Singer, Thomas, Hansel, Trevor T., Manigold, Tobias“…BACKGROUND: Alfa-interferons (IFNα2a, IFNα2b, 40KDa-PEGIFNα2a and 12KDa-PEGIFNα2b) are effective treatments for chronic hepatitis C infection. However, their usage has been associated with a variety of adverse events, including interstitial pneumonitis and pulmonary arterial hypertension. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13950por Waheed, Yasir, Saeed, Umar, Anjum, Sadia, Afzal, Mohammad Sohail, Ashraf, Muhammad“…BACKGROUND: Hepatitis C virus (HCV) is a plus stranded RNA virus which encodes 10 different genes. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13951por Bala, Shashi, Tilahun, Yaphet, Taha, Odette, Alao, Hawau, Kodys, Karen, Catalano, Donna, Szabo, Gyongyi“…BACKGROUND: Hepatitis C Virus (HCV), a single stranded RNA virus, affects millions of people worldwide and leads to chronic infection characterized by chronic inflammation in the liver and in peripheral immune cells. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13952por Swart, Alexander, Burns, Lucinda, Mao, Limin, Grulich, Andrew E, Amin, Janaki, O'Connell, Dianne L, Meagher, Nicola S, Randall, Deborah A, Degenhardt, Louisa, Vajdic, Claire M“…OBJECTIVE: To quantify cancer risk in opioid dependence and the association with infection by the oncogenic blood-borne viruses (BBVs) hepatitis C (HCV), hepatitis B (HBV) and HIV. DESIGN: Cohort study. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13953“…BACKGROUND: Oral lichen planus (OLP) is seen frequently in patients with hepatitis C virus (HCV) infection. The aim of this study was to evaluate the occurrence of oral candidiasis, other mucosal lesions, and xerostomia during interferon (IFN) therapy for HCV infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13954“…BACKGROUND: Patients receiving maintenance haemodialysis (HD) are at higher risk for acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general population. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13955por Petta, Salvatore, Macaluso, Fabio Salvatore, Barcellona, Maria Rosa, Cammà, Calogero, Cabibi, Daniela, Di Marco, Vito, Craxì, Antonio“…In patients with nonalcoholic fatty liver disease (NAFLD), genotype 1 chronic hepatitis C (G1CHC) and chronic hepatitis B (CHB), we assessed the link between liver fibrosis and γ-GT serum levels, and we evaluated if normal or high γ-GT serum levels affect the association between insulin resistance (IR) and severity of liver fibrosis. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13956por Wichadakul, Duangdao, Mhuantong, Wuttichai, Jongkaewwattana, Anan, Ingsriswang, Supawadee“…To make the computational flow easily accessible by virologists, we also developed MicroLive, a web server version of the MRE design flow together with the database of miranda-predicted MREs within gene sequences of seven RNA viruses including Influenza A, dengue, hepatitis C, measles, mumps, poliovirus, and rabies. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13957por Pellicelli, Adriano M, Romano, Mario, Stroffolini, Tommaso, Mazzoni, Ettore, Mecenate, Fabrizio, Monarca, Roberto, Picardi, Antonio, Bonaventura, Maria Elena, Mastropietro, Cristina, Vignally, Pascal, Andreoli, Arnaldo, Marignani, Massimo, D’Ambrosio, Cecilia, Miglioresi, Lucia, Nosotti, Lorenzo, Mitidieri, Olga, Gentilucci, Umberto Vespasiani, Puoti, Claudio, Barbaro, Giuseppe, Barlattani, Angelo, Furlan, Caterina, Barbarini, Giorgio“…BACKGROUND: The impact of viral subtype on the rate of sustained virological response (SVR) to antiviral therapy in patients chronically infected with hepatitis C genotype 1 subtype 1a and 1b has not been extensively investigated. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13958por Roux, Perrine, Michel, Laurent, Cohen, Julien, Mora, Marion, Morel, Alain, Aubertin, Jean-Francois, Desenclos, Jean-Claude, Spire, Bruno, Carrieri, Patrizia M“…BACKGROUND: In France, the rapid scale-up of buprenorphine, an opioid maintenance treatment (OMT), in primary care for drug users has led to an impressive reduction in HIV prevalence among injecting drug users (IDU) but has had no major effect on Hepatitis C incidence. To date, patients willing to start methadone can only do so in a methadone clinic (a medical centre for drug and alcohol dependence (CSAPA) or a hospital setting) and are referred to primary care physicians after dose stabilization. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13959por Thorsteinsson, Kristina, Ladelund, Steen, Jensen-Fangel, Søren, Johansen, Isik Somuncu, Katzenstein, Terese L, Pedersen, Gitte, Storgaard, Merete, Obel, Niels, Lebech, Anne-Mette“…METHODS: From a nationwide cohort of Danish HIV infected individuals we identified all heterosexually infected women (N=587) and heterosexually infected men (N=583) with no record of Hepatitis C infection diagnosed with HIV after 1 January 1997. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13960por Lund, Ingunn O, Kirtadze, Irma, Otiashvili, David, O’Grady, Kevin E, Jones, Hendrée E“…BACKGROUND: HIV and Hepatitis C virus (HCV) infections are strongly related to injection drug use in the Republic of Georgia. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto